![Thomas F. Keller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas F. Keller
Directeur/Membre du Conseil chez
Child Care Services Association
Profil
Thomas F.
Keller is currently the Director at Child Care Services Association.
Prior to this, he was a Director at Biogen MA, Inc., DIMON, Inc., and Hatteras Income Securities, Inc. He also served as a Director at Biogen, Inc. In addition, he was a Professor at Duke University from 1974 to 2004.
From 1991 to 2008, he was a Director at Wendy's International LLC.
He was also a Director at Biogen Idec New Ventures, Inc. from 1996 to 2007.
Postes actifs de Thomas F. Keller
| Sociétés | Poste | Début |
|---|---|---|
Child Care Services Association
 Child Care Services Association Services to the Health IndustryHealth Services Provides social services for children | Directeur/Membre du Conseil | 13/11/2009 |
Anciens postes connus de Thomas F. Keller
| Sociétés | Poste | Fin |
|---|---|---|
Hatteras Income Securities, Inc.
 Hatteras Income Securities, Inc. Investment Trusts/Mutual FundsMiscellaneous Closed-End Investment Fund/Investment Trust | Directeur/Membre du Conseil | 23/03/2013 |
Wendy's International LLC
 Wendy's International LLC RestaurantsConsumer Services Operates fast food restaurants | Directeur/Membre du Conseil | 29/09/2008 |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Directeur/Membre du Conseil | 31/12/2007 |
DIMON, Inc.
 DIMON, Inc. Wholesale DistributorsDistribution Services Purchases, stores, and sells leaf tobacco | Directeur/Membre du Conseil | 16/05/2005 |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/09/2004 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Develops and manufactures drugs related to immunology, neurobiology and oncology | Health Technology |
DIMON, Inc.
DIMON, Inc. Wholesale DistributorsDistribution Services Purchases, stores, and sells leaf tobacco | Distribution Services |
Hatteras Income Securities, Inc.
Hatteras Income Securities, Inc. Investment Trusts/Mutual FundsMiscellaneous Closed-End Investment Fund/Investment Trust | Miscellaneous |
Wendy's International LLC
Wendy's International LLC RestaurantsConsumer Services Operates fast food restaurants | Consumer Services |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Finance |
Child Care Services Association
Child Care Services Association Services to the Health IndustryHealth Services Provides social services for children | Health Services |
